Accelerating pandemic response: The swine flu vaccine

Talking Swine Flu at BioFinance

Discussing the recent outbreak of Influenza A Virus H1N1 at last week’s BioFinance, Dr. Gottlieb, former Deputy Commissioner of the FDA, examines the evolution of vaccine manufacturing capacity from the days of Avian flu to the current crisis.

Outbreaks, breakthroughs, and other game-changing events in medical science require the medical industry to respond rapidly, redeploying resources, and altering business strategies to stay relevant in a dynamic market climate. Coming up with ways of hard-coding adaptive agility and market awareness into company operations at an early stage means fewer battles and faster cures down the road.

Accelerating Pandemic Response: The Swine Flu Vaccine from MaRS Discovery District on Vimeo.

Related Blogs

 

When politics meets public health
veryone loves an underdog. And in science, when your theories start out being dismissed by one’s esteemed colleagues, it must be particularly sweet to prove the mainstream wrong with a Nobel Pr

Canada to the rescue!
Over 90,000 infected. Over 400 dead in over 70 countries. The swine flu seems unstoppable. To address the pandemic, we need accurate monitoring. Infonaut is a made-in-Canada solution (and MaRS client

Tags: biofinance, H1N1, vaccine, virus